Researchers discover a vulnerability in immunotherapy-resist

Researchers at Vanderbilt-Ingram Cancer Center have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

Related Keywords

Susang Komen , Paula Gonzalez Ericsson , Melinda Sanders , Xiaopeng Sun , Brian Lehmann , Vandana Abramson , Elizabeth Wescott , Brandiec Taylor , Jennifer Pietenpol , Ann Hanna , Lily Ramsey , Justin Balko , Susan Opalenik , Ingram Associate Professor Of Cancer Research , National Institutes Of Health , Department Of Defense , Balko Lab , Researchers At Vanderbilt Ingram Cancer Center , Vanderbilt Ingram Cancer Center , Cancer Discovery , Ingram Associate Professor , Cancer Research , National Institutes , Breast Cancer , Dancer , Immunotherapy , Chemotherapy , Drugs , Immune System , Olecule , Natural Killer Cells , Research , Humor ,